In this study, we profiled the cytokine-chemokine serum levels associated with prostate cancer and demonstrated that serum chemokines CXCL2, CXCL5, and CCL23 are the most distinguished chemokines differentially expressed in men of AA and CA races. The gene discussed is CXCL2; the disease is prostate carcinoma.